• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Merck signs up to $3.3 billion cancer drug deal with LaNova

    REUTERS

    Merck Licenses LM-299, Anti-PD-1/VEGF Bispecific Antibody

    BUSINESSWIRE

    LaNova Initiates Phase 1 Trial Of Bispecific Antibody LM-299

    PR NEWSWIRE

    AstraZeneca enters potential $600M licensing deal with Chinese startup

    ENDPTS

    LaNova enters exclusive license agreement with AstraZeneca for LM-305

    PHARMABIZ

    LaNova Medicines Announces Global Exclusive License Agreement with AZ for LM-305

    PR NEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.